René Lattmann

856 total citations
17 papers, 665 citations indexed

About

René Lattmann is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, René Lattmann has authored 17 papers receiving a total of 665 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Oncology. Recurrent topics in René Lattmann's work include Porphyrin Metabolism and Disorders (3 papers), Metal complexes synthesis and properties (3 papers) and Enzyme Catalysis and Immobilization (3 papers). René Lattmann is often cited by papers focused on Porphyrin Metabolism and Disorders (3 papers), Metal complexes synthesis and properties (3 papers) and Enzyme Catalysis and Immobilization (3 papers). René Lattmann collaborates with scholars based in Switzerland, Germany and United States. René Lattmann's co-authors include Pierre Acklin, Hans Peter Schnebli, Bernard Faller, Hanspeter Nick, Suzanne Hauffe, Uwe Heinz, Κ. Hegetschweiler, Daniele Alberti, Albert Eschenmoser and Leoluca Criscione and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and Journal of Medicinal Chemistry.

In The Last Decade

René Lattmann

17 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
René Lattmann Switzerland 11 227 181 164 146 80 17 665
Yoshiaki Nabuchi United States 13 487 2.1× 59 0.3× 155 0.9× 67 0.5× 30 0.4× 32 956
Michael P. Carroll United States 14 270 1.2× 101 0.6× 193 1.2× 377 2.6× 20 0.3× 22 825
Peter Zbinden Switzerland 13 283 1.2× 82 0.5× 125 0.8× 148 1.0× 34 0.4× 22 622
Alban J. Allentoff United States 15 344 1.5× 91 0.5× 112 0.7× 150 1.0× 29 0.4× 36 845
Zudong Liu United Kingdom 10 153 0.7× 80 0.4× 80 0.5× 116 0.8× 107 1.3× 11 540
A J Kraker United States 13 265 1.2× 135 0.7× 245 1.5× 232 1.6× 29 0.4× 18 879
Surinder S. Narula United States 15 377 1.7× 21 0.1× 107 0.7× 111 0.8× 79 1.0× 25 743
Makoto Hiromura Japan 17 440 1.9× 20 0.1× 56 0.3× 102 0.7× 36 0.5× 40 1.0k
Régis Leung-Toung Canada 18 199 0.9× 35 0.2× 47 0.3× 519 3.6× 46 0.6× 24 827
Neil G. Almstead United States 20 669 2.9× 58 0.3× 80 0.5× 628 4.3× 32 0.4× 44 1.6k

Countries citing papers authored by René Lattmann

Since Specialization
Citations

This map shows the geographic impact of René Lattmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by René Lattmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites René Lattmann more than expected).

Fields of papers citing papers by René Lattmann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by René Lattmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by René Lattmann. The network helps show where René Lattmann may publish in the future.

Co-authorship network of co-authors of René Lattmann

This figure shows the co-authorship network connecting the top 25 collaborators of René Lattmann. A scholar is included among the top collaborators of René Lattmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with René Lattmann. René Lattmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Shaw, Duncan, Simona Cotesta, René Lattmann, et al.. (2023). Design and Synthesis of Inhibitors of the E3 Ligase SMAD Specific E3 Ubiquitin Protein Ligase 1 as a Treatment for Lung Remodeling in Pulmonary Arterial Hypertension. Journal of Medicinal Chemistry. 66(12). 8130–8139. 3 indexed citations
2.
Kallen, Joerg, René Lattmann, Marcel J. J. Blommers, et al.. (2007). Crystal Structure of Human Estrogen-related Receptor α in Complex with a Synthetic Inverse Agonist Reveals Its Novel Molecular Mechanism. Journal of Biological Chemistry. 282(32). 23231–23239. 76 indexed citations
3.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2007). 2-Cyano-pyrimidines:  A New Chemotype for Inhibitors of the Cysteine Protease Cathepsin K. Journal of Medicinal Chemistry. 50(4). 591–594. 23 indexed citations
4.
Altmann, Eva, Reiner Aichholz, Claudia Betschart, et al.. (2006). Dipeptide nitrile inhibitors of cathepsin K. Bioorganic & Medicinal Chemistry Letters. 16(9). 2549–2554. 19 indexed citations
5.
Nick, Hanspeter, et al.. (2003). Development of Tridentate Iron Chelators: From Desferrithiocin to ICL670. Current Medicinal Chemistry. 10(12). 1065–1076. 139 indexed citations
6.
Nick, Hanspeter, Pierre Acklin, Bernard Faller, et al.. (2002). ICL670A: Preclinical Profile. Advances in experimental medicine and biology. 509. 185–203. 59 indexed citations
7.
Heinz, Uwe, Κ. Hegetschweiler, Pierre Acklin, et al.. (1999). 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]- benzoic Acid: A Novel Efficient and Selective Iron(III) Complexing Agent. Angewandte Chemie International Edition. 38(17). 2568–2570. 116 indexed citations
8.
Heinz, Uwe, Κ. Hegetschweiler, Pierre Acklin, et al.. (1999). 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoesäure: ein neuartiger, effizienter und selektiver Eisen(III)-Komplexbildner. Angewandte Chemie. 111(17). 2733–2736. 8 indexed citations
9.
Heinz, Uwe, Κ. Hegetschweiler, Pierre Acklin, et al.. (1999). 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]- benzoic Acid: A Novel Efficient and Selective Iron(III) Complexing Agent. Angewandte Chemie International Edition. 38(17). 2568–2570. 4 indexed citations
10.
Bühlmayer, Peter, Leoluca Criscione, Marc de Gasparo, et al.. (1994). Valsartan, a potent, orally active angiotensin II antagonist developed from the structurally new amino acid series. Bioorganic & Medicinal Chemistry Letters. 4(1). 29–34. 82 indexed citations
11.
Kittelmann, Matthias, René Lattmann, & Oreste Ghisalba. (1993). Preparation of 10,11-Epoxy-carbamazepine and 10,11-Dihydro-10-hydroxy-carbamazepine by Microbial Epoxidation and Hydroxylation. Bioscience Biotechnology and Biochemistry. 57(9). 1589–1590. 7 indexed citations
12.
Ghisalba, Oreste, et al.. (1991). Enzymatic preparation of acylglycerols of high optical purity. Recueil des Travaux Chimiques des Pays-Bas. 110(5). 263–264. 12 indexed citations
13.
Lattmann, René, Oreste Ghisalba, Daniel Gygax, Hans‐Peter Schär, & Elke Schmidt. (1990). Screening and Application of Microbial Esterases for the Enantioselective Synthesis of Chiral Glycerol Derivatives. Biocatalysis. 3(1-2). 137–144. 7 indexed citations
14.
Ksander, Gary M., Guido Bold, René Lattmann, et al.. (1987). Chemie der α‐Aminonitrile 1. Mitteilung Einleitung und Wege zu Uroporphyrinogen‐octanitrilen. Helvetica Chimica Acta. 70(4). 1115–1172. 74 indexed citations
15.
Lattmann, René. (1983). Synthetische Studien in der Hydroporphyrinreihe. Repository for Publications and Research Data (ETH Zurich). 6 indexed citations
16.
Lattmann, René, et al.. (1980). Synthesis and Transformations of 5‐Cyano‐2,2,8,8,12,13,17,18‐octamethylisobacteriochlorin. Angewandte Chemie International Edition in English. 19(2). 143–145. 17 indexed citations
17.
Lattmann, René, et al.. (1980). Synthese und Umwandlungen des 5-Cyan-2,2,8,8,12,13,17,18-octamethyl-isobakteriochlorins. Angewandte Chemie. 92(2). 143–144. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoshiaki Nabuchi Breakdown of academic impact, for papers by Michael P. Carroll Breakdown of academic impact, for papers by Peter Zbinden Breakdown of academic impact, for papers by Alban J. Allentoff Breakdown of academic impact, for papers by Zudong Liu Breakdown of academic impact, for papers by A J Kraker Breakdown of academic impact, for papers by Surinder S. Narula Breakdown of academic impact, for papers by Makoto Hiromura Breakdown of academic impact, for papers by Régis Leung-Toung Breakdown of academic impact, for papers by Neil G. Almstead
Rankless by CCL
2026